Skip to content

We Just Heard About Omicron, But a Company Announced That It Has ‘Vaccine’ in Testing for It?!

    Donald Winslow Published on November 28, 2021

    Now would you look at that! They’ve entangled themselves in what seems to be pretty obvious!

    The world is on edge of another quarantine holiday season. Are they doing this on purpose?

    “In the United States, New York’s governor Kathy Hochul has already canceled elective surgeries in the state citing the Omicron variant, even as the transmissibility and deadliness of this latest Covid mutation are unknown. The variant is believed to have originated in Botswana, and may be playing a role in a Covid surge in South Africa.”

    The variant has been identified in Botswana, South Africa, Hong Kong, and Amsterdam in The Netherlands.
    But listen to the tremendous fact reported by Reuters.
    “Pfizer-BioNTech, fresh off sky-high profits off of its government-mandated ‘vaccines,’ is already mulling a ‘future relaunch‘ of a Covid-19 vaccine to deal with the Omicron variant. It looks like a lesser-known pharmaceutical company, Novavax, however, may beat it to the punch.
    Novavax said on Friday it has “started working on a version of its COVID-19 vaccine to target the variant detected in South Africa” and “would have the shot ready for testing and manufacturing in the next few weeks.”
    “The company’s COVID-19 shot contains an actual version of the virus’ spike protein that cannot cause disease but can trigger the immune system,” Reuters noted. “The vaccine developer said it had started developing a spike protein specifically based on the known genetic sequence of the variant, B.1.1.529.”
    “The initial work will take a few weeks,” a company spokesperson said. “Shares of the company closed up nearly 9% on Friday.”
    The report notes that Novavax’s vaccine received its first emergency use approval earlier this month in Indonesia, followed by the Philippines
    “The company has said it is on track to file for U.S. approval by the end of the year,” the report continued. “It has also filed for approvals with the European Medicines Agency as well as in Canada.”
    Before SARS-CoV-2 burst onto the global scene in December 2019, it was expected that a vaccine took years of testing and development. I guess that stood for illnesses and viruses that weren’t genetically modified and created by humans, right?

    Leave a Comment